AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
W. Carter Neild is a Managing Partner at OrbiMed. His official profile states that he joined the firm in 2002 and led expansion in areas including healthcare royalty opportunities and Asia private investments. Earlier in his career, he was a Director in UBS Alternative Investments Group and worked in the investment management division of First Chicago, now part of J.P. Morgan. He holds an MBA in Finance from the University of Chicago, a CFA charter, a BA in Economics from Emory University, and a CEP from the Institute d'Etudes Politiques in Paris.
Investment focus
Stage, sector, and overall fit
Stage
healthcare private investmentsroyalty opportunitiesgrowth and private equity
Sector
healthcarelife sciencesAsia private investmentshealthcare royalties
Thesis
Healthcare royalty opportunitiesAsia private investmentsHealthcare and life sciences private investments
Notable companies
Selected portfolio companies the partner has backed
UBS Alternative Investments GroupFirst ChicagoJ.P. Morgan
How to approach
Framing and angles for outreach
Pitch framing
Frame opportunities around healthcare market expansion, royalty structures, or Asia-related private investment relevance.
Personalization hooks
- 1Healthcare royalties and Asia private investments
- 2University of Chicago Booth and private equity networks
- 3Literary interests and racquet sports noted on official profile
Background
Career, education, and skills
Career history
- OrbiMedManaging Partner2002
- UBSDirector, Alternative Investments Group2002
- First Chicago (now J.P. Morgan)Investment Management4 years
Education
- University of Chicago Booth School of BusinessM.B.A., Finance
- Emory UniversityB.A., Economics
- Institut d'Études Politiques, ParisC.E.P.1991
Skills
Healthcare investingRoyalty financingPrivate equityAsia investmentsCFA
Languages
EnglishFrench (atrophied)
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.